Top news of the day from across the health care landscape.
SPT Staff
Advertisement
Articles by SPT Staff
Top news of the week from Specialty Pharmacy Times.
Top news of the day from across the health care landscape.
Top news of the day from across the health care landscape.
Top news of the day from across the health care landscape
Top news of the day from across the health care landscape
Top news of the day from across the health care landscape
Top news of the week from Specialty Pharmacy Times.
Top news of the day from across the health care landscape
Top news of the day from across the health care landscape
Top news of the day from across the health care landscape.
Top news of the day from across the health care landscape.
Top news of the week from Specialty Pharmacy Times.
Top news of the day from across the health care landscape.
Top news of the day from across the health care landscape.
Top news of the day from across the health care landscape.
Top news of the day from across the health care landscape.
Top news of the day from across the health care landscape.
Top news of the day from across the health care landscape.
Top news of the week from Specialty Pharmacy Times.
Top news of the day from across the health care landscape.
Top news of the day from across the health care landscape.
Top news of the day from across the health care landscape.
Top news of the day from across the health care landscape.
Top news of the week from Specialty Pharmacy Times.
Top news of the day from across the health care landscape.
Combination of Lenvima and Keytruda awarded second Breakthrough Therapy designation for the treatment of endometrial carcinoma.
Top news of the day from across the health care landscape.
Top news of the day from across the health care landscape.
Hepatitis B virus core inhibitor under evaluation in a pair of global phase 2a proof of concept studies.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
Study: Many Patients Switching Biologics Because of Perceived Lack of Efficacy Treating Asthma
2
ADCs in Breast Cancer: Shaping the Future of HER2– and TROP2-Targeted Therapy
3
FDA Approves Targeted Combination Therapy for BRCA2-Mutated Prostate Cancer
4
Targeted ADCs Break Through Barriers in HER2-Positive Breast Cancer
5
